Brokerages Set Phreesia, Inc. (NYSE:PHR) PT at $31.00

Phreesia, Inc. (NYSE:PHR - Get Free Report) has been assigned an average recommendation of "Buy" from the twelve brokerages that are presently covering the company, MarketBeat reports. Twelve analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $31.00.

A number of brokerages recently issued reports on PHR. KeyCorp lifted their target price on Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a report on Wednesday, January 8th. Citigroup upped their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, January 10th. Truist Financial lifted their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Robert W. Baird reduced their price target on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a research report on Wednesday, December 11th. Finally, JMP Securities reiterated a "market outperform" rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th.

Phreesia Price Performance

NYSE:PHR traded down $0.27 during mid-day trading on Thursday, reaching $26.83. 199,775 shares of the stock were exchanged, compared to its average volume of 389,527. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The business has a fifty day moving average price of $23.30 and a 200 day moving average price of $22.74. Phreesia has a 1-year low of $17.07 and a 1-year high of $29.16. The firm has a market capitalization of $1.56 billion, a PE ratio of -18.25 and a beta of 0.94.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to analysts' expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business's revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.58) EPS. Research analysts expect that Phreesia will post -1.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Amy Beth Vanduyn sold 25,447 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $20.93, for a total transaction of $532,605.71. Following the transaction, the senior vice president now owns 93,470 shares in the company, valued at $1,956,327.10. This represents a 21.40 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Balaji Gandhi sold 3,195 shares of Phreesia stock in a transaction on Monday, January 6th. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95. Following the completion of the sale, the chief financial officer now directly owns 148,509 shares of the company's stock, valued at approximately $3,951,824.49. The trade was a 2.11 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 93,324 shares of company stock valued at $2,190,773 in the last three months. Insiders own 5.80% of the company's stock.

Institutional Trading of Phreesia

Large investors have recently made changes to their positions in the stock. International Assets Investment Management LLC raised its stake in shares of Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock valued at $33,000 after acquiring an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp bought a new position in shares of Phreesia in the second quarter valued at approximately $202,000. Point72 DIFC Ltd bought a new position in shares of Phreesia in the second quarter valued at approximately $209,000. XTX Topco Ltd acquired a new stake in shares of Phreesia in the third quarter worth $247,000. Finally, Hsbc Holdings PLC bought a new stake in shares of Phreesia during the 2nd quarter worth $301,000. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.